(ANDG) Andersen - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: (N/A)
Stock: Tax Services, Financial Advisory, Valuation Services
Total Rating 55
Risk 64
Buy Signal 1.61
| Risk 5d forecast | |
|---|---|
| Volatility | 80.0% |
| Relative Tail Risk | 5.53% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.03 |
| Alpha | 63.12 |
| Character TTM | |
|---|---|
| Beta | -0.707 |
| Beta Downside | 9.990 |
| Drawdowns 3y | |
|---|---|
| Max DD | 30.56% |
| CAGR/Max DD | 17.04 |
EPS (Earnings per Share)
Revenue
Description: ANDG Andersen March 04, 2026
Andersen Group Inc. (ANDG) offers tax, valuation, and financial advisory services. The company serves individuals, family offices, businesses, and institutional clients across the United States.
Its service lines include private client services, business tax services, alternative investment fund services, and valuation services. Private client services address wealth management, charitable giving, and estate planning for high-net-worth individuals. Business tax services focus on tax planning, compliance, and reporting for corporate entities. Alternative investment fund services cater to various fund structures, including private equity and hedge funds, a growing segment in financial markets. Valuation services assist clients with tax and regulatory compliance, a critical component of corporate governance.
Founded in 2002 and headquartered in San Francisco, California, Andersen Group Inc. operates as a subsidiary of Andersen Aggregator LLC. The company operates within the Research & Consulting Services sub-industry, a sector characterized by specialized knowledge and client-specific solutions. Investors can find further detailed analysis on ValueRay.
Headlines to watch out for
- Wealth management demand fuels private client service revenue
- Business tax compliance needs drive consulting growth
- Alternative investment fund activity impacts service volume
- Regulatory changes create new demand for valuation services
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 56.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.26 > 0.02 and ΔFCF/TA -5.11 > 1.0 |
| NWC/Revenue: 23.35% < 20% (prev 19.88%; Δ 3.46% < -1%) |
| CFO/TA 0.27 > 3% & CFO 152.3m > Net Income 56.0m |
| Net Debt (293.8m) to EBITDA (70.1m): 4.19 < 3 |
| Current Ratio: 1.84 > 1.5 & < 3 |
| Outstanding Shares: last quarter (11.0m) vs 12m ago 0.0% < -2% |
| Gross Margin: 26.47% > 18% (prev 0.37%; Δ 2.61k% > 0.5%) |
| Asset Turnover: 173.9% > 50% (prev 194.1%; Δ -20.27% > 0%) |
| Interest Coverage Ratio: 1.33 > 6 (EBITDA TTM 70.1m / Interest Expense TTM 45.8m) |
Altman Z'' 3.05
| A: 0.34 (Total Current Assets 413.6m - Total Current Liabilities 224.3m) / Total Assets 563.1m |
| B: -0.01 (Retained Earnings -4.81m / Total Assets 563.1m) |
| C: 0.13 (EBIT TTM 61.1m / Avg Total Assets 466.3m) |
| D: -0.01 (Book Value of Equity -4.80m / Total Liabilities 610.8m) |
| Altman-Z'' Score: 3.05 = A |
Beneish M -2.48
| DSRI: 1.66 (Receivables 212.2m/113.2m, Revenue 810.8m/717.3m) |
| GMI: 1.38 (GM 26.47% / 36.56%) |
| AQI: 0.57 (AQ_t 0.06 / AQ_t-1 0.11) |
| SGI: 1.13 (Revenue 810.8m / 717.3m) |
| TATA: -0.17 (NI 56.0m - CFO 152.3m) / TA 563.1m) |
| Beneish M-Score: -2.48 (Cap -4..+1) = BBB |
What is the price of ANDG shares?
As of March 19, 2026, the stock is trading at USD 24.89 with a total of 314,430 shares traded.
Over the past week, the price has changed by +20.92%, over one month by +26.21%, over three months by +11.30% and over the past year by +76.69%.
Over the past week, the price has changed by +20.92%, over one month by +26.21%, over three months by +11.30% and over the past year by +76.69%.
Is ANDG a buy, sell or hold?
Andersen has no consensus analysts rating.
What are the forecasts/targets for the ANDG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 29.5 | 18.5% |
| Analysts Target Price | - | - |
ANDG Fundamental Data Overview March 19, 2026
P/S = 3.4062
Revenue TTM = 810.8m USD
EBIT TTM = 61.1m USD
EBITDA TTM = 70.1m USD
Long Term Debt = 287.9m USD (from longTermDebt, last quarter)
Short Term Debt = 79.0m USD (from shortTermDebt, last quarter)
Debt = 461.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 293.8m USD (from netDebt column, last quarter)
Enterprise Value = 2.88b USD (2.59b + Debt 461.5m - CCE 176.9m)
Interest Coverage Ratio = 1.33 (Ebit TTM 61.1m / Interest Expense TTM 45.8m)
EV/FCF = 20.01x (Enterprise Value 2.88b / FCF TTM 143.7m)
FCF Yield = 5.00% (FCF TTM 143.7m / Enterprise Value 2.88b)
FCF Margin = 17.73% (FCF TTM 143.7m / Revenue TTM 810.8m)
Net Margin = 6.91% (Net Income TTM 56.0m / Revenue TTM 810.8m)
Gross Margin = 26.47% ((Revenue TTM 810.8m - Cost of Revenue TTM 596.1m) / Revenue TTM)
Gross Margin QoQ = 55.51% (prev -29.14%)
Tobins Q-Ratio = 5.11 (Enterprise Value 2.88b / Total Assets 563.1m)
Interest Expense / Debt = 4.24% (Interest Expense 19.5m / Debt 461.5m)
Taxrate = 6.61% (7.87m / 119.0m)
NOPAT = 57.1m (EBIT 61.1m * (1 - 6.61%))
Current Ratio = 1.84 (Total Current Assets 413.6m / Total Current Liabilities 224.3m)
Debt / Equity = -96.22 (negative equity) (Debt 461.5m / totalStockholderEquity, last quarter -4.80m)
Debt / EBITDA = 4.19 (Net Debt 293.8m / EBITDA 70.1m)
Debt / FCF = 2.04 (Net Debt 293.8m / FCF TTM 143.7m)
Total Stockholder Equity = 141.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 12.01% (Net Income 56.0m / Total Assets 563.1m)
RoE = 39.48% (Net Income TTM 56.0m / Total Stockholder Equity 141.8m)
RoCE = 14.23% (EBIT 61.1m / Capital Employed (Equity 141.8m + L.T.Debt 287.9m))
RoIC = 16.49% (NOPAT 57.1m / Invested Capital 346.3m)
WACC = 3.41% (E(2.59b)/V(3.05b) * Re(3.31%) + D(461.5m)/V(3.05b) * Rd(4.24%) * (1-Tc(0.07)))
Discount Rate = 3.31% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 0.0 | Cagr: 0.0%
[DCF] Terminal Value 88.43% ; FCFF base≈131.5m ; Y1≈162.2m ; Y5≈276.3m
[DCF] Fair Price = 612.7 (EV 8.04b - Net Debt 293.8m = Equity 7.75b / Shares 12.7m; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -100.0 | EPS CAGR: -100.00% | SUE: N/A | # QB: 0
Revenue Correlation: 40.36 | Revenue CAGR: 16.05% | SUE: N/A | # QB: 0
EPS next Year (2026-12-31): EPS=1.51 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+0 | Growth EPS=-3.5% | Growth Revenue=+13.1%
Revenue TTM = 810.8m USD
EBIT TTM = 61.1m USD
EBITDA TTM = 70.1m USD
Long Term Debt = 287.9m USD (from longTermDebt, last quarter)
Short Term Debt = 79.0m USD (from shortTermDebt, last quarter)
Debt = 461.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 293.8m USD (from netDebt column, last quarter)
Enterprise Value = 2.88b USD (2.59b + Debt 461.5m - CCE 176.9m)
Interest Coverage Ratio = 1.33 (Ebit TTM 61.1m / Interest Expense TTM 45.8m)
EV/FCF = 20.01x (Enterprise Value 2.88b / FCF TTM 143.7m)
FCF Yield = 5.00% (FCF TTM 143.7m / Enterprise Value 2.88b)
FCF Margin = 17.73% (FCF TTM 143.7m / Revenue TTM 810.8m)
Net Margin = 6.91% (Net Income TTM 56.0m / Revenue TTM 810.8m)
Gross Margin = 26.47% ((Revenue TTM 810.8m - Cost of Revenue TTM 596.1m) / Revenue TTM)
Gross Margin QoQ = 55.51% (prev -29.14%)
Tobins Q-Ratio = 5.11 (Enterprise Value 2.88b / Total Assets 563.1m)
Interest Expense / Debt = 4.24% (Interest Expense 19.5m / Debt 461.5m)
Taxrate = 6.61% (7.87m / 119.0m)
NOPAT = 57.1m (EBIT 61.1m * (1 - 6.61%))
Current Ratio = 1.84 (Total Current Assets 413.6m / Total Current Liabilities 224.3m)
Debt / Equity = -96.22 (negative equity) (Debt 461.5m / totalStockholderEquity, last quarter -4.80m)
Debt / EBITDA = 4.19 (Net Debt 293.8m / EBITDA 70.1m)
Debt / FCF = 2.04 (Net Debt 293.8m / FCF TTM 143.7m)
Total Stockholder Equity = 141.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 12.01% (Net Income 56.0m / Total Assets 563.1m)
RoE = 39.48% (Net Income TTM 56.0m / Total Stockholder Equity 141.8m)
RoCE = 14.23% (EBIT 61.1m / Capital Employed (Equity 141.8m + L.T.Debt 287.9m))
RoIC = 16.49% (NOPAT 57.1m / Invested Capital 346.3m)
WACC = 3.41% (E(2.59b)/V(3.05b) * Re(3.31%) + D(461.5m)/V(3.05b) * Rd(4.24%) * (1-Tc(0.07)))
Discount Rate = 3.31% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 0.0 | Cagr: 0.0%
[DCF] Terminal Value 88.43% ; FCFF base≈131.5m ; Y1≈162.2m ; Y5≈276.3m
[DCF] Fair Price = 612.7 (EV 8.04b - Net Debt 293.8m = Equity 7.75b / Shares 12.7m; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -100.0 | EPS CAGR: -100.00% | SUE: N/A | # QB: 0
Revenue Correlation: 40.36 | Revenue CAGR: 16.05% | SUE: N/A | # QB: 0
EPS next Year (2026-12-31): EPS=1.51 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+0 | Growth EPS=-3.5% | Growth Revenue=+13.1%